In recent decades and years, there's a paradigm shift in autism science moving from the medical deficit model / classification as neurodevelopmental disorder / medical model of disability to the neurodiversity model, aligned with the social model of disability. (See e.g. Pellicano & den Houting 2022, Annual Research Review: Shifting from 'normal science' to neurodiversity in autism science)
Now, strangely, at the same time there are signs that in Finland there are forces which attempt to make a shift from the neurodevelopmental medical deficit model of neurodivergency to a disease model, as if neurotypes were not permanent but something that comes and goes.
Is this peculiar phenomenon of reframing divergent neurotypes - or, in medical deficit model parlance, diagnoses like ASD, ADHD, Tourettes - as "neuropsychiatric symptoms" specific to Finland, or does it happen elsewhere too?
Jugding from English search engine hits, "neuropsychiatric symptoms" has a different meaning altogether, mostly used in connection to Alzheimer's disease.
Shared is one example from an academy project, but this has become common also with the government and other sectors, perhaps before academy.
ping @ReimanSaara
#autism #autists #neurodiversity #neurodivergent #socialmodel #diseasemodel #medicalmodel
https://www.linkedin.com/posts/activity-7081897442907967488-W-N7